Restoring Vision with Stem Cells | Eyestem | Made with Endiya
Summary
Eyestem is tackling one of the most complex and underserved challenges in healthcare: irreversible vision loss caused by retinal degeneration. Diseases such as age-related macular degeneration (AMD) and other retinal disorders progressively destroy photoreceptor cells in the eye, leading to permanent blindness. Globally, millions of people are affected, with limited treatment options available once the damage reaches an advanced stage. Existing therapies can slow progression in some cases but rarely restore lost vision. The core problem is biological - human retinal cells do not regenerate naturally, and once lost, they cannot be replaced through conventional medicine.
Eyestem’s approach is rooted in regenerative medicine, specifically the use of stem cell-derived therapies to replace damaged retinal cells. By developing retinal pigment epithelial (RPE) cells from stem cells, Eyestem aims to restore the function of the retina at a cellular level. These lab-grown cells are designed to integrate into the patient’s eye, support surviving photoreceptors, and potentially bring back lost visual function. The company is building scalable, high-quality manufacturing processes to ensure these cells can be produced consistently and safely for clinical use.
What makes this approach compelling is its potential to shift treatment from management to restoration. Instead of slowing decline, Eyestem is working toward reversing damage - addressing the root cause rather than symptoms. If successful, this could redefine how degenerative eye diseases are treated, moving from chronic care to one-time or limited interventions with long-term impact. In doing so, Eyestem is not just developing a therapy, but opening a pathway to restoring vision for millions who currently have no viable options.
Made with Endiya - Episode 3 features Eyestem, a company working to restore vision through stem cell science. Watch the full story on YouTube, Spotify, and Apple Podcasts.